Akselos
Venture Round in 2022
Akselos is a technology company that develops Integra, a cloud-based engineering simulation platform and digital twin for asset-centric industries. The platform enables engineers to build high-resolution, component-based models of large systems and run parameterized simulations that cover geometric and physical properties, loads, and boundary conditions. It supports hydrodynamic analysis of floating assets and structural assessment of fixed offshore installations, as well as analysis of composites used in wind blades, pressure vessels, pipelines, and rotating machines. Designed for design, virtual prototyping, and real-time monitoring, Integra leverages fast, patented algorithms that can model large-scale assets on portable hardware. The company's vision emphasizes preventative maintenance and reduced unplanned downtime through real-time asset condition and future-state insights, often described as a digital twin with sensors and big data analytics. Akselos was founded in 2011 in Lausanne, with a Cambridge, Massachusetts office and operations in Europe, the USA, and Southeast Asia.
ObvioHealth
Series B in 2021
ObvioHealth is a global digital health organization focused on enhancing clinical trials through innovative technology. The company provides a mobile clinical study application that facilitates site-less trial designs, enabling participants to engage in remote monitoring from their homes. This application supports continuous data collection between clinic visits, ensuring robust data acquisition and improved participant compliance. By utilizing features such as text messaging and chatbots, ObvioHealth fosters daily interaction with trial subjects, enhancing their involvement in the process. The platform also integrates seamlessly with various health devices, including smartwatches and activity trackers, which aids in collecting real-world data. Additionally, participants can manage lab visit scheduling and receive compensation through their connected accounts. By streamlining communication through chat or video, ObvioHealth significantly improves the clinical trial experience for both sponsors and participants, leading to faster recruitment and reduced trial completion times.
Global Growth
Series A in 2020
Global Growth is a multinational private investment firm that focuses on acquiring and investing in various sectors, including healthcare technology, communications, financial services, and business software. The company strategically targets businesses involved in insurance and annuities, media, market intelligence, and certification, offering services such as training, market research, advertising, and information services. By leveraging its expertise, Global Growth aims to enhance the performance and value of its portfolio companies while delivering strong returns to its investors.
Clovia is a lingerie brand that specializes in manufacturing and selling a diverse range of products, including fashion lingerie, innerwear, nightwear, and shapewear. Aimed at Indian women, Clovia addresses the need for stylish and comfortable undergarments, moving away from traditional one-size-fits-all options. The company operates over 200 stores across 50 locations, providing women with access to designer-quality lingerie at affordable prices. Clovia's focus on solution-based, premium products positions it as a modern alternative in the lingerie market, catering to the evolving preferences of its customers.
Lenddo International, established in 2011, operates an online platform enabling users to leverage their social network reputation for accessing local financial services. Headquartered in Hong Kong with offices in the Philippines, Colombia, and New York, Lenddo serves customers in Colombia and the Philippines, offering loans for education, debt consolidation, appliances, medical expenses, home improvements, or small businesses. It uses data from users' online social connections to assess creditworthiness, making financial services more accessible. As of October 2017, Lenddo operates as a subsidiary of EFL Global Ltd.